Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Gemoscan Canada Announces Appointment of Vice President, Investor Relations
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
Pacific Safety Products Inc. Announces Terminatio .. of Intent to Sell Substantially All of its Assets
[ Mon, Mar 05th 2012 ] - Market Wire
Lilly Pledges $100,000 to American Red Cross' Tornado Disaster Relief Efforts
[ Mon, Mar 05th 2012 ] - Market Wire
BIOLASE Declares Stock Dividend for 2012 First Quarter
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
[ Mon, Mar 05th 2012 ] - Market Wire
Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar
[ Mon, Mar 05th 2012 ] - Market Wire
New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit
[ Mon, Mar 05th 2012 ] - Market Wire
Liezel Huber Hopes to Dominate at This Week's BNP Paribas Open
[ Mon, Mar 05th 2012 ] - Market Wire
Unigene's Proprietary Peptelligencea" Platform Se .. ealth Peptides for an Oral Phase 1 Clinical Study
[ Mon, Mar 05th 2012 ] - Market Wire
Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med
[ Mon, Mar 05th 2012 ] - Market Wire
BioDelivery Sciences to Present at Cowen and ROTH Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference
[ Mon, Mar 05th 2012 ] - Market Wire
The Ensign Group Announces Acquisition of Doctors Express Franchise System
[ Mon, Mar 05th 2012 ] - Market Wire
OncoSec to Present at Cowen and ROTH Healthcare Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice
[ Mon, Mar 05th 2012 ] - Market Wire
diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe
Fri, March 2, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Receives Marketing Authorization in Europe .. Union for VEPACEL Pre-Pandemic Influenza Vaccine
[ Fri, Mar 02nd 2012 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the Cowen and Co. Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
[ Fri, Mar 02nd 2012 ] - Market Wire
Alere to Attend the Raymond James amp;; As .. stitutional Investors Conference on March 6, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status
[ Fri, Mar 02nd 2012 ] - Market Wire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
[ Fri, Mar 02nd 2012 ] - Market Wire
Syneron Closes Acquisition of Ultrashape Ltd.
[ Fri, Mar 02nd 2012 ] - Market Wire
Amerigroup Expands Operations in Texas
[ Fri, Mar 02nd 2012 ] - Market Wire
Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control
[ Fri, Mar 02nd 2012 ] - Market Wire
Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec
[ Fri, Mar 02nd 2012 ] - Market Wire
ProMetic Announces Changes to Its Board of Directors
[ Fri, Mar 02nd 2012 ] - Market Wire
Given Imaging Supports Fight Against Colorectal Cancer
[ Fri, Mar 02nd 2012 ] - Market Wire
SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial
[ Fri, Mar 02nd 2012 ] - Market Wire
Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress
[ Fri, Mar 02nd 2012 ] - Market Wire
IRIDEX to Present at Upcoming Investment Conferences
[ Fri, Mar 02nd 2012 ] - Market Wire
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
[ Fri, Mar 02nd 2012 ] - Market Wire
Concord Medical to Report Fourth Quarter and Full Year 2011 Financial Results on March 21, 2012
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Idenix Pharmaceuticals Elects Thomas Hodgson as C .. Appoints Michael Wyzga to Its Board of Directors
[ Thu, Mar 01st 2012 ] - Market Wire
IMRIS reports fourth quarter and annual 2011 financial results
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Avanir Pharmaceuticals to Participate in Two Conferences in March
[ Thu, Mar 01st 2012 ] - Market Wire
Helix BioPharma Corp. Announces L-DOS47 Scientifi .. the Second Annual IBC Conference on Analytical Te
[ Thu, Mar 01st 2012 ] - Market Wire
Abbott to Build Nutrition Manufacturing Facility in Ohio
[ Thu, Mar 01st 2012 ] - Market Wire
Southern Home Medical Provides Corporate Overview for Shareholders and Financial Industry
[ Thu, Mar 01st 2012 ] - Market Wire
Tibet Pharmaceuticals, Inc. Announces Receipt of .. g Privatequot;; Proposal at $3.00 Per Shar
[ Thu, Mar 01st 2012 ] - Market Wire
Novelos Therapeutics and Academic Collaborators H .. pted for Presentation at 2012 AACR Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Cantel Medical Corp. to Hold Conference Call to D .. lts for Its Second Quarter Ended January 31, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Boston Scientific Announces Launch of PROMUS Elementa" Platinum Chromium Stent System in Japan
[ Thu, Mar 01st 2012 ] - Market Wire
Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
[ Thu, Mar 01st 2012 ] - Market Wire
Hamilton Thorne Expands Distribution Partnership .. e and Optical Systems Producer Leica Microsystems
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Amica Mature Lifestyles Increases Ownership in Amica at Dundas
[ Thu, Mar 01st 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Fina .. 11 and Host a Conference Call to Update Investors
[ Thu, Mar 01st 2012 ] - Market Wire
Digirad Corporation Board of Directors Adopts Strengthened Charter and Policies
[ Thu, Mar 01st 2012 ] - Market Wire
Novadaq Announces NASDAQ Listing
[ Thu, Mar 01st 2012 ] - Market Wire
Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Mar 01st 2012 ] - Market Wire
Herborium Group to Begin Commercialization of its .. roducts With Aggressive Plans to Take a Bite of a
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.;; BUY
[ Wed, Feb 29th 2012 ] - Market Wire
Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Thera Max Cold and Flu Brand Receives Great Benef .. Ongoing Social Media Marketing Awareness Program
[ Wed, Feb 29th 2012 ] - Market Wire
Celsion to Present at Upcoming Investor Conferences in March 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Levetiracetam Oral Solution
[ Wed, Feb 29th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Announces Present .. ons at Two Upcoming Investor Conferences in March
[ Wed, Feb 29th 2012 ] - Market Wire
Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Avanir Pharmaceuticals and Concert Pharmaceutical .. to Develop and Commercialize Deuterium-modified D
[ Wed, Feb 29th 2012 ] - Market Wire
AMRI Expands Quality Control Leadership to Support Future Growth
[ Wed, Feb 29th 2012 ] - Market Wire
Mylan Launches First Equivalent Product to Lexapro Tablets
[ Wed, Feb 29th 2012 ] - Market Wire
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2012 Results
[ Wed, Feb 29th 2012 ] - Market Wire
Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer
[ Wed, Feb 29th 2012 ] - Market Wire
Horizon Pharma Announces $50.8 Million Private Placement
[ Wed, Feb 29th 2012 ] - Market Wire
Arrowhead Announces Patent Issuance Covering siRNA Inhibitors of HIF-2a (EPAS1)
[ Wed, Feb 29th 2012 ] - Market Wire
BioLineRx Announces Receipt of Notice of Allowanc .. ing BCM (BL-1040), a Novel Medical Device for Pre
[ Wed, Feb 29th 2012 ] - Market Wire
Biogen Idec levert aanvraag in bij FDA voor goedk .. ale BG-12 voor behandeling van Multiple Sclerosis
[ Wed, Feb 29th 2012 ] - Market Wire
Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
ProMetic Finalizes Its Agreement With Celgene Corporation
[ Wed, Feb 29th 2012 ] - Market Wire
OncoSec's OMS ElectroOncology Technology Platform .. n Medical Device amp;; Diagnostic Industry
[ Wed, Feb 29th 2012 ] - Market Wire
Auxilium Partners With the National Organization for Rare Disorders to Observe Rare Disease Day
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Announces Investigation of China Sky One Medical, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
Lucid, Inc. Announces Separation of Unit to Common Stock and Warrant
[ Tue, Feb 28th 2012 ] - Market Wire
Healthways to Present at the Barclays Capital Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Cowen 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Co .. en and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
AdCare Health Systems to Present at the ROTH Capi .. Partners 24th Annual Conference on March 12, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
AVI BioPharma Announces FDA Approval to Proceed W .. Dosing of AVI-6003 for Treatment of Marburg Virus
[ Tue, Feb 28th 2012 ] - Market Wire
ARIAD Reports 2011 Financial Results and Outlines .. Development and Commercialization Plans for 2012
[ Tue, Feb 28th 2012 ] - Market Wire
POZEN Reports Fourth Quarter & Year End 2011 Results
[ Tue, Feb 28th 2012 ] - Market Wire
UnitedHealthcare to Strengthen Service to Florida .. of Preferred Care Partners and Medica Healthcare
[ Tue, Feb 28th 2012 ] - Market Wire
Aviation Security in China Continues to Purchase .. lant Sciences' Explosives Trace Detection Devices
[ Tue, Feb 28th 2012 ] - Market Wire
BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
[ Tue, Feb 28th 2012 ] - Market Wire
Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12
[ Tue, Feb 28th 2012 ] - Market Wire
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
[ Tue, Feb 28th 2012 ] - Market Wire
Astex Pharmaceuticals to Announce 2011 Fourth Qua .. r and Year-End Financial Results on March 5, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Inovio Pharmaceuticals to Present at Cowen and ROTH Investor Conferences
Mon, February 27, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
Forest Laboratories, Inc. and Gedeon Richter Plc. .. ositive Phase III Trials with the Investigational
[ Mon, Feb 27th 2012 ] - Market Wire
BioLineRx Ltd. Announces Closing of $15 Million Private Placement to Institutional Investors
[ Mon, Feb 27th 2012 ] - Market Wire
Cloudant Names Andy Palmer to Its Board of Directors
[ Mon, Feb 27th 2012 ] - Market Wire
BrainStorm'sNurOwna" Stem Cell Technology Offers Hope for Treating Huntington Disease
[ Mon, Feb 27th 2012 ] - Market Wire
Alexion to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Mon, Feb 27th 2012 ] - Market Wire
CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012
[ Mon, Feb 27th 2012 ] - Market Wire
OPKO Invests in BioZone Pharmaceuticals, Inc.
[ Mon, Feb 27th 2012 ] - Market Wire
Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide Conference
[ Mon, Feb 27th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation
[ Mon, Feb 27th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Akorn, Inc. and Ironwood Pharmaceuticals, Inc.
[ Mon, Feb 27th 2012 ] - Market Wire
Cancer Therapies From Dendreon and AEterna Zentaris Poised to Boost Profits
[ Mon, Feb 27th 2012 ] - Market Wire
Cancer Treatments Evolve - Exelixis and Seattle Genetics Look to Lead
[ Mon, Feb 27th 2012 ] - Market Wire
St. Jude Medical Announces Increase in Quarterly Dividend
[ Mon, Feb 27th 2012 ] - Market Wire
ARIAD to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Mon, Feb 27th 2012 ] - Market Wire
VentriPoint Completes Validation Study for Pulmonary Arterial Hypertension Application
[ Mon, Feb 27th 2012 ] - Market Wire
Brookdale to Present at 2012 RBC Capital Markets' Healthcare Conference on February 29
[ Mon, Feb 27th 2012 ] - Market Wire
Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference
[ Mon, Feb 27th 2012 ] - Market Wire
Delcath Announces First CHEMOSAT Procedures in Germany
[ Mon, Feb 27th 2012 ] - Market Wire
Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
PAREXEL International to Present at Cowen Healthc .. Conference and Raymond James Investors Conference
Sat, February 25, 2012
[ Sat, Feb 25th 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against TranS1 Inc.
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
Nektar to Announce Financial Results for the Four .. 11 on Wednesday, February 29, 2012, After Close o
[ Fri, Feb 24th 2012 ] - Market Wire
Update on Motion for Authorization to Institute Class Action Against the Company
[ Fri, Feb 24th 2012 ] - Market Wire
Aetna Board of Directors Declares Quarterly Cash Dividend, Authorizes Additional Share Repurchases
[ Fri, Feb 24th 2012 ] - Market Wire
Greatbatch, Inc. to Participate in the 2012 RBC Capital Marketsa Healthcare Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Dual Inhibition of MET and VEGF Signaling With Ca .. zantinib Blocks Tumor Invasiveness and Metastasis
[ Fri, Feb 24th 2012 ] - Market Wire
International Drug & Explosives Detection Company .. enta Corp. Announces Orders Since January 1, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
IGSM GROUP INC., Holding Company Completes First Acquisition
[ Fri, Feb 24th 2012 ] - Market Wire
Perception, Opportunity in Volatility - Research .. is on VIVUS, Inc. and Arena Pharmaceuticals, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
BIOLASE Announces the Introduction of the Waterla .. Lasers at the Chicago Dental Society Midwinter M
[ Fri, Feb 24th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Becton, .. on and Co. and Health Management Associates, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
NxStage Kicks Off Annual Dialysis Conference 2012 .. brity and Former NxStage User Stephen Furst and O
[ Fri, Feb 24th 2012 ] - Market Wire
Titan Medical Inc. Lists on OTCQX Market in the USA
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
[ Fri, Feb 24th 2012 ] - Market Wire
Heska Announces Quarterly Dividend of $0.10 per Share
[ Fri, Feb 24th 2012 ] - Market Wire
HERBORIUM GROUP Announces Signing the Letter of I .. ina Health Resource Inc. for Possible Acquisition
[ Fri, Feb 24th 2012 ] - Market Wire
SANUWAVE Announces Distribution Agreement for Canada
[ Fri, Feb 24th 2012 ] - Market Wire
OncoSec to Present at 10th Annual BioPartnering North America
[ Fri, Feb 24th 2012 ] - Market Wire
Threshold Pharmaceuticals to Present at the Cowen Health Care Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
DURECT to Participate in Upcoming Healthcare Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Citi 2012 Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Hospira Joins the Generic Pharmaceutical Association
[ Thu, Feb 23rd 2012 ] - Market Wire
Amarantus BioSciences to Present at the 2012 Nati .. ent Banking Association Conference in New Orleans
[ Thu, Feb 23rd 2012 ] - Market Wire
BIOLASE and Cefla Dental Group Announce Exclusive Distribution Agreement
[ Thu, Feb 23rd 2012 ] - Market Wire
SecureAlert, Inc. Reports Record Monitoring Revenues
[ Thu, Feb 23rd 2012 ] - Market Wire
PROLOR Biotech to Present Preclinical Data on Its .. ors VIIa and IX at European Hemophilia Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Theragenics Reports Revenue & Earnings for Fourth Quarter & Year-End 2011
[ Thu, Feb 23rd 2012 ] - Market Wire
MAP Pharmaceuticals Issued Additional U.S. Patent .. id Treatment of Migraine Based Upon Pharmacokinet
[ Thu, Feb 23rd 2012 ] - Market Wire
Nuvo Research provides an update on its Pennsaid franchise
[ Thu, Feb 23rd 2012 ] - Market Wire
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
[ Thu, Feb 23rd 2012 ] - Market Wire
Implant Sciences' Quantum Sniffer Explosives and .. Be Exhibited at Security Trade Show in Madrid, Sp
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
[ Thu, Feb 23rd 2012 ] - Market Wire
PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
[ Thu, Feb 23rd 2012 ] - Market Wire
Teleflex Introduces the FloCath Quicka" Female Catheter and Insertion Kit
Wed, February 22, 2012
[ Wed, Feb 22nd 2012 ] - Market Wire
INSERTING and REPLACING Human Genome Sciences to .. scuss Fourth-Quarter and Full-Year 2011 Financial
[ Wed, Feb 22nd 2012 ] - Market Wire
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R)
[ Wed, Feb 22nd 2012 ] - Market Wire
Hospira to Present at the Barclays Capital Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Boston Scientific to Participate in 2012 RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Hologic to Launch Four New Products at the European Congress of Radiology in Vienna
[ Wed, Feb 22nd 2012 ] - Market Wire
AT&T Selected as Carrier to Connect Boston Scient .. vices: Offering Physician and Patient Convenience
[ Wed, Feb 22nd 2012 ] - Market Wire
Mettler-Toledo International Inc. Announces Webcast of Presentation at Citi Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Concentra Selects Allscripts Electronic Health Record for Concentra Medical Centers
[ Wed, Feb 22nd 2012 ] - Market Wire
Critical Outcome Technologies Inc. Selected for Trade Mission to BioPartnering North America
[ Wed, Feb 22nd 2012 ] - Market Wire
AVI BioPharma Regains NASDAQ Compliance
[ Wed, Feb 22nd 2012 ] - Market Wire
Synta Provides Clinical Update and Reports Fourth Quarter and Year End 2011 Financial Results
[ Wed, Feb 22nd 2012 ] - Market Wire
Shire Announces European Approval of Manufacturing Facility for VPRIV (velaglucerase alfa)
[ Wed, Feb 22nd 2012 ] - Market Wire
US Patent Office Rejects All Claims in Second MonoSol Patent
[ Wed, Feb 22nd 2012 ] - Market Wire
SciClone Pharmaceuticals to Present at RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Marina Biotech Receives Notice of Allowance for U .. s Lipid Based Nucleic Acid Drug Delivery Platform
[ Wed, Feb 22nd 2012 ] - Market Wire
PAREXEL to Address Proven Approaches to Realize S .. lue at Partnerships in Clinical Trials Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
The Ensign Group, Inc. Secures $21.5 Million Loan From RBS Asset Finance, Inc.
[ Wed, Feb 22nd 2012 ] - Market Wire
Centene Corporation Awarded Missouri Managed Care Contract
[ Wed, Feb 22nd 2012 ] - Market Wire
Lexicon Pharmaceuticals Provides Clinical Pipelin .. 11 Fourth Quarter and Full Year Financial Results
[ Wed, Feb 22nd 2012 ] - Market Wire
Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Prestige Brands Holdings, Inc. Reacts to Unsolici .. inding Highly-Conditional Letter from Genomma Lab
[ Tue, Feb 21st 2012 ] - Market Wire
Life Technologies to Present at Barclays Capital Global Healthcare Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Vanguard Health Systems to Participate in Investor Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Elan to Present at Cowen & Co., 32nd Annual Healthcare Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Mylan Provides Blueprint for 2012 and Beyond
[ Tue, Feb 21st 2012 ] - Market Wire
Regeneron Announces February 2012 Investor Conference Presentations
[ Tue, Feb 21st 2012 ] - Market Wire
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Natus Medical to Hold 2011 Fourth Quarter Financial Results Conference Call on February 28
[ Tue, Feb 21st 2012 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against BioSante Pharmaceuticals, Inc.
[ Tue, Feb 21st 2012 ] - Market Wire
Magellan Health Services to Present at Upcoming Investor Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Black Smoker Corporate Update
[ Tue, Feb 21st 2012 ] - Market Wire
DHR International Completes Search for Sparton Corporation
[ Tue, Feb 21st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Prestige Brands Holdings, Inc.
[ Tue, Feb 21st 2012 ] - Market Wire
Ligand to Present at the Citi Global Health Care Conference on February 28th
[ Tue, Feb 21st 2012 ] - Market Wire
Mylan Secures an Additional $300 Million of Committed Financing
[ Tue, Feb 21st 2012 ] - Market Wire
Natus to Present at Citi 2012 Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
A Phase 3 Study to Assess Repeat Treatment Effica .. 0MG TID in Subjects with Irritable Bowel Syndrome
[ Tue, Feb 21st 2012 ] - Market Wire
Hospira Works With FDA to Help Avert Methotrexate .. One Month's Supply of New Product Immediately and
[ Tue, Feb 21st 2012 ] - Market Wire
Community Health Systems, Inc. to Participate in Two Investor Conferences in February

Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. -company-32nd-annual-health-care-conference.html
Published in Health and Fitness on Tuesday, February 28th 2012 at 4:15 GMT by Market Wire   Print publication without navigation


Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health... -- CARLSBAD, Calif., Feb. 28, 2012 /PRNewswire/ --

Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

[ ]

CARLSBAD, Calif., Feb. 28, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: [ ISIS ]), the leader in antisense therapeutics, today announced that management will present a company overview at Cowen and Company's 32nd Annual Health Care Conference on Tuesday, March 06, 2012 at 10:40 a.m. ET at the Boston Marriot Copley Place.  

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, [ www.isispharm.com ].  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at [ www.isispharm.com ].

SOURCE Isis Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.isispharm.com ]


Publication Contributing Sources